|
1）中島 淳，本多 靖，結束貴臣，他．【腸内細菌研究の展望】腸内細菌は非アルコール性脂肪性肝炎(NASH)とどのようにかかわっているか．分子消化器病．2014; 11: 227-32
|
|
|
|
2）Bischoff SC, Barbara G, Buurman W, et al. Intestinal permeability--a new target for disease prevention and therapy. BMC Gastroenterol. 2014; 14: 189
|
|
|
|
|
3）Sequeira IR, Lentle RG, Kruger MC, et al. Standardising the lactulose mannitol test of gut permeability to minimise error and promote comparability. PLoS One. 2014; 9: e99256
|
|
|
|
|
4）Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010; 16: 2978-90
|
|
|
|
|
|
5）加藤真吾，稲森正彦．【消化器感染症-慢性炎症-消化器機能障害，この三角関係をみつめる】Small intestinal bacterial overgrowthはIBS症状の原因となるか．分子消化器病．2013; 10: 254-60
|
|
|
|
|
|
6）安藤 朗，高橋憲一郎，藤本剛英，他．【糖尿病と消化器疾患】糖尿病と小腸疾患SIBO，腸内細菌のエネルギー獲得における役割．GIResearch. 2013; 21: 208-14
|
|
|
|
|
|
7）大久保秀則，中島 淳．【下痢と便秘-近年の診断と治療の進歩】下痢症への対処 短腸症候群，Bacterial overgrowthによる下痢の治療．診断と治療．2013; 101: 257-61
|
|
|
|
|
|
8）Sabate JM, Jouet P, Harnois F, et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg. 2008; 18: 371-7
|
|
|
|
|
|
9）Schwiertz A, Taras D, Schafer K, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2010; 18: 190-5
|
|
|
|
|
|
10）Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature. 2006; 444: 1022-3
|
|
|
|
|
|
11）Kim HK, Youn BS, Shin MS, et al. Hypothalamic Angptl4/Fiaf is a novel regulator of food intake and body weight. Diabetes. 2010; 59: 2772-80
|
|
|
|
|
|
12）Muccioli GG, Naslain D, Backhed F, et al. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol. 2010; 6: 392
|
|
|
|
|
|
13）Suzuki T, Hara H. Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab (Lond). 2010; 7: 19
|
|
|
|
|
|
14）Teixeira TF, Collado MC, Ferreira CL, et al. Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr Res. 2012; 32: 637-47
|
|
|
|
|
|
15）Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998; 114: 842-5
|
|
|
|
|
|
16）Harte AL, da Silva NF, Creely SJ, et al. Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond). 2010; 7: 15
|
|
|
|
|
|
17）Triger DR, Boyer TD, Levin J. Portal and systemic bacteraemia and endotoxaemia in liver disease. Gut. 1978; 19: 935-9
|
|
|
|
|
|
18）Imajo K, Fujita K, Yoneda M, et al. Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling. Cell Metab. 2012; 16: 44-54
|
|
|
|
|
|
19）Miele L, Valenza V, La Torre G, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009; 49: 1877-87
|
|
|
|
|
|
20）Perrier C, Corthesy B. Gut permeability and food allergies. Clin Exp Allergy. 2011; 41: 20-8
|
|
|
|
|
|
21）Camilleri M, Madsen K, Spiller R, et al. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil. 2012; 24: 503-12
|
|
|
|
|
|
22）Fresko I, Hamuryudan V, Demir M, et al. Intestinal permeability in Behçet's syndrome. Ann Rheum Dis. 2001; 60: 65-6
|
|
|
|
|
|
23）Johnson AM, Costanzo A, Gareau MG, et al. High fat diet causes depletion of intestinal eosinophils associated with intestinal permeability. PLoS One. 2015; 10: e0122195
|
|
|
|
|
|
24）Szabo G. Gut-liver axis in alcoholic liver disease. Gastroenterology. 2015; 148: 30-6
|
|
|
|
|